Search Results

HEROES-DCB Trial to Compare Lutonix and In.Pact Drug-Coated Balloons

May 11, 2016—Advocate Heart Institute of Oak Lawn, Illinois announced the initiation of the HEROES-DCB trial to evaluate the efficacy of the Lutonix (Bard Peripheral Vascular) and In.Pact (Medtronic) drug-coated balloons (DCBs) with respect to patient outcomes.  HEROES-DCB is a prospective, randomized clinical trial to determine if there is a difference in clinical outcomes between US Food and Drug Administration-approved DCBs to treat peripheral artery disease (PAD).

Gore Announces 2014 Pioneers in Performance for North America

November 19, 2014—Gore & Associates announced the North American physicians being honored with the company’s 2014 Pioneers in Performance award.

Avinger’s Tigereye ST Image-Guided CTO Crossing System Cleared by FDA

April 26, 2023—Avinger, Inc. announced FDA 510(k) clearance for Tigereye ST, the company’s next-generation image-guided chronic total occlusion (CTO) crossing system.

FDA Approves Boston Scientific's Innova Stent System for SFA/PPA Treatment

August 19, 2015—Boston Scientific Corporation announced that the company has received US Food and Drug Administration (FDA) approval for the Innova vascular self-expanding stent system to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA) or proximal popliteal artery (PPA).